445 related articles for article (PubMed ID: 22609029)
1. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
Bordalo AD; Nobre AL; Dantas M; Cravino J
Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
3. The relation between homocysteine and calcific aortic valve stenosis.
Gunduz H; Arinc H; Tamer A; Akdemir R; Ozhan H; Binak E; Uyan C
Cardiology; 2005; 103(4):207-11. PubMed ID: 15838165
[TBL] [Abstract][Full Text] [Related]
4. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
[TBL] [Abstract][Full Text] [Related]
5. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
6. Lipid profile in patients with coronary artery disease.
Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
[TBL] [Abstract][Full Text] [Related]
7. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.
Novaro GM; Pearce GL; Sprecher DL; Griffin BP
J Heart Valve Dis; 2001 Jan; 10(1):19-24. PubMed ID: 11206763
[TBL] [Abstract][Full Text] [Related]
9. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
[TBL] [Abstract][Full Text] [Related]
10. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid and lipoprotein profile abnormality in predicting the risk of coronary artery disease in non-diabetic patients attending NMCTH, Birgunj.
Adak M; Shivapuri JN
Nepal Med Coll J; 2010 Sep; 12(3):158-64. PubMed ID: 21446364
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?
Uzunlulu M; Oğuz A; Tigen K
Anadolu Kardiyol Derg; 2005 Dec; 5(4):268-70. PubMed ID: 16330390
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
14. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients.
Tseng CH; Tseng CP; Chong CK; Cheng JC; Tai TY
Int J Cardiol; 2006 Jul; 111(1):80-5. PubMed ID: 16213608
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
17. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
Shahid HS; Kurdi MI; Zohair AA
Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
[TBL] [Abstract][Full Text] [Related]
19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
20. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
